scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1015516129 |
P356 | DOI | 10.1007/S13277-016-5123-X |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s13277-016-5123-x |
P698 | PubMed publication ID | 27329104 |
P50 | author | Mohamed El-Shinawi | Q59697022 |
Sherif A Ibrahim | Q59705197 | ||
Mona Mostafa Mohamed | Q62592797 | ||
P2093 | author name string | Amal Youns | |
Mohamed Akram Nouh | |||
Tahani El-Mamlouk | |||
Zeinab Hussein | |||
Eslam A Elghonaimy | |||
P2860 | cites work | Significance of axillary lymph node metastasis in primary breast cancer | Q73181668 |
Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion | Q24321517 | ||
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
Molecular mechanisms of epithelial-mesenchymal transition | Q27013743 | ||
Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications | Q28076697 | ||
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Q28293535 | ||
Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development | Q30311953 | ||
Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3 | Q30440581 | ||
RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells | Q33688924 | ||
Why not treat human cancer with interleukin-1 blockade? | Q33833871 | ||
Epithelial-mesenchymal transition: NF-kappaB takes center stage | Q34367143 | ||
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes | Q34411361 | ||
Cathepsin B: a potential prognostic marker for inflammatory breast cancer | Q34499322 | ||
Interleukin-6 increases expression and secretion of cathepsin B by breast tumor-associated monocytes | Q34537360 | ||
NF-κB-induced KIAA1199 promotes survival through EGFR signalling | Q34563758 | ||
Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation | Q34978807 | ||
Molecular signatures of lymph node status by intrinsic subtype: gene expression analysis of primary breast tumors from patients with and without metastatic lymph nodes | Q35066446 | ||
Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling | Q35083176 | ||
Insights into the mechanisms of lymph node metastasis | Q35181938 | ||
Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment | Q35463907 | ||
Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer | Q35586223 | ||
NF-κB, stem cells and breast cancer: the links get stronger | Q35608668 | ||
Expression of EMT Markers SLUG and TWIST in Breast Cancer. | Q35678230 | ||
Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells | Q35710589 | ||
Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1 | Q35952706 | ||
Capturing and characterizing immune cells from breast tumor microenvironment: an innovative surgical approach. | Q36109399 | ||
Metastasis: recent discoveries and novel treatment strategies | Q36407511 | ||
Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention | Q36638387 | ||
Knockdown of PSCA induces EMT and decreases metastatic potentials of the human prostate cancer DU145 cells | Q36687126 | ||
Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression | Q36945006 | ||
Immune cells as mediators of solid tumor metastasis | Q37027344 | ||
IL4 and IL-17A provide a Th2/Th17-polarized inflammatory milieu in favor of TGF-β1 to induce bronchial epithelial-mesenchymal transition (EMT). | Q37054538 | ||
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression | Q37286365 | ||
Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. | Q37346143 | ||
Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines | Q37356654 | ||
Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties | Q37592080 | ||
Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links | Q38007261 | ||
Tectorigenin ablates the inflammation-induced epithelial-mesenchymal transition in a co-culture model of human lung carcinoma. | Q38906344 | ||
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells. | Q38911110 | ||
Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factor | Q38914414 | ||
Activated macrophages down-regulate expression of E-cadherin in hepatocellular carcinoma cells via NF-κB/Slug pathway | Q38988561 | ||
Positive lymph-node breast cancer patients – activation of NF-κB in tumor-associated leukocytes stimulates cytokine secretion that promotes metastasis via C-C chemokine receptor CCR7. | Q39110988 | ||
CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling | Q39155541 | ||
The p65 subunit of NF-κB and PARP1 assist Snail1 in activating fibronectin transcription | Q39416485 | ||
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer | Q39893964 | ||
Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition | Q40120833 | ||
FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer | Q41548013 | ||
Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma. | Q53627868 | ||
Analysis of epidermal growth factor-induced NF-κB signaling. | Q55066424 | ||
Nuclear Factor-kB Tumor Expression Predicts Response and Survival in Irinotecan-Refractory Metastatic Colorectal Cancer Treated With Cetuximab-Irinotecan Therapy | Q57758325 | ||
P2507 | corrigendum / erratum | Erratum to: Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-kB/p65 signaling pathway | Q46588347 |
P433 | issue | 9 | |
P921 | main subject | NF-κB | Q411114 |
secretome | Q17042943 | ||
P304 | page(s) | 12441-12453 | |
P577 | publication date | 2016-06-22 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway | |
P478 | volume | 37 |
Q33869755 | EMT and inflammation: inseparable actors of cancer progression. |
Q47716837 | Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools. |
Q97645872 | HB-EGF Activates the EGFR/HIF-1α Pathway to Induce Proliferation of Arsenic-Transformed Cells and Tumor Growth |
Q64119982 | MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2 |
Q38659528 | Proteomic profiling of the cancer cell secretome: informing clinical research. |
Q37686006 | Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways |
Q50308942 | Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway. |
Q46588347 | Erratum to: Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-kB/p65 signaling pathway | main subject | P921 |
Search more.